FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival

ABSTRACT Background FXYD3 is a Na/K‐ATPase modulator which is upregulated in pancreatic ductal adenocarcinoma (PDAC), but its prognostic role is unknown. This study evaluated FXYD3 expression in chemo‐naive patients with surgically‐resected PDAC at a single centre (1993–2014). Method FXYD3 expressio...

Descrición completa

Detalles Bibliográficos

Principais autores:	Nathalie B. Rasko, Christopher B. Nahm, John Turchini, Rachel Teh, Helge Rasmussen, Sooin Byeon, Sumit Sahni, Jaswinder S. Samra, Anthony J. Gill, Anubhav Mittal
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2025-01-01
Series:	Cancer Medicine
Assuntos:	FXYD3 MAT‐8 pancreatic cancer pancreatic ductal adenocarcinoma prognosis survival
Acceso en liña:	https://doi.org/10.1002/cam4.70500
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!